Hi-Tech (HITK) lands final FDA approval for its seizure treatment Levetiracetam. The drug is a...

|About: Hi-Tech Pharmacal Co., Inc. (HITK)|By:, SA News Editor

Hi-Tech (HITK) lands final FDA approval for its seizure treatment Levetiracetam. The drug is a generic version of UCB Pharma’s Keppra oral solution which had combined brand and generic sales of $62M in 2011. Shares +1.3% premarket.